estramustine and Liver-Diseases

estramustine has been researched along with Liver-Diseases* in 1 studies

Other Studies

1 other study(ies) available for estramustine and Liver-Diseases

ArticleYear
[Chemotherapy with low-dose docetaxel and estramustine phosphate in patient with liver dysfunction due to liver metastases of hormone-refractory prostate cancer : a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:1

    A 82-year-old man was referred to our hospital for treatment of hormone-refractory prostate cancer with liver metastases. The obstruction of intrahepatic bile ducts due to the rapid growth of liver metastases induced liver dysfunction. We administered 25 mg/m(2) docetaxel on day1 and 280 mg/body estramustine phosphate on day 1 to day 3, every 4 weeks. After two courses of this combined chemothrapy, the liver metastases were markedly reduced in size with the rapid improvement of liver function.

    Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Estramustine; Humans; Liver Diseases; Liver Neoplasms; Male; Prostatic Neoplasms; Taxoids

2010